| Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps V Papayannopoulos, KD Metzler, A Hakkim, A Zychlinsky Journal of cell biology 191 (3), 677-691, 2010 | 2153 | 2010 |
| Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis A Hakkim, BG Fürnrohr, K Amann, B Laube, UA Abed, V Brinkmann, ... Proceedings of the National Academy of Sciences 107 (21), 9813-9818, 2010 | 1668 | 2010 |
| Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation A Hakkim, TA Fuchs, NE Martinez, S Hess, H Prinz, A Zychlinsky, ... Nature chemical biology 7 (2), 75-77, 2011 | 775 | 2011 |
| Restoration of NET formation by gene therapy in CGD controls aspergillosis M Bianchi, A Hakkim, V Brinkmann, U Siler, RA Seger, A Zychlinsky, ... Blood, The Journal of the American Society of Hematology 114 (13), 2619-2622, 2009 | 689 | 2009 |
| Intestinal epithelial Wnt signaling mediates acetylcholine-triggered host defense against infection SA Labed, KA Wani, S Jagadeesan, A Hakkim, M Najibi, JE Irazoqui Immunity 48 (5), 963-978. e3, 2018 | 73 | 2018 |
| Quorum‐sensing regulator RhlR but not its autoinducer RhlI enables Pseudomonas to evade opsonization S Haller, A Franchet, A Hakkim, J Chen, E Drenkard, S Yu, S Schirmeier, ... EMBO reports 19 (5), e44880, 2018 | 29 | 2018 |
| The selective estrogen receptor modulator raloxifene inhibits neutrophil extracellular trap formation R Flores, S Döhrmann, C Schaal, A Hakkim, V Nizet, R Corriden Frontiers in immunology 7, 566, 2016 | 27 | 2016 |
| Means and methods for identifying an increased risk of systemic lupus erythematosus (SLE) patients for developing renal manifestations A Zychlinsky, AH Rahamathullah, V Brinkmann, R Voll US Patent App. 13/642,568, 2013 | 9 | 2013 |
| RNAi Screening: Automated High‐Throughput Liquid RNAi Screening in Caenorhabditis elegans S Jagadeesan, A Hakkim Current protocols in molecular biology 124 (1), e65, 2018 | 8 | 2018 |
| Neutrophil extracellular traps TA Fuchs, A Hakkim, CF Urban Inflammation: fundamental mechanisms, 205-275, 2018 | 5 | 2018 |
| Response: Protecting against Aspergillus infection in CGD A Hakkim, R Hurwitz, M Bianchi, V Brinkmann, U Siler, RA Seger, ... Blood, The Journal of the American Society of Hematology 114 (16), 3498-3498, 2009 | 4 | 2009 |
| Engineering of DNASE enzymes for manufacturing and therapy TA Fuchs US Patent 11,840,712, 2023 | 1 | 2023 |
| Manufacturing and engineering of DNASE enzymes for therapy TA Fuchs US Patent 10,988,746, 2021 | 1 | 2021 |
| Dnase1-like 3 and its use in therapy TA Fuchs US Patent App. 16/915,547, 2020 | 1 | 2020 |
| ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY TA Fuchs, AR Hakkim US Patent App. 18/497,106, 2024 | | 2024 |
| Engineering of DNASE enzymes for manufacturing and therapy TA Fuchs US Patent 11,578,314, 2023 | | 2023 |
| Plate Design for and Cherry Picking of Bacterial RNAi Clones for Systematic Error Detection in High‐Throughput Caenorhabditis elegans RNAi Screens S Jagadeesan, A Hakkim Current protocols in molecular biology 124 (1), e70, 2018 | | 2018 |
| SECONDARY METABOLITE SCREENING SYSTEM FA Ajikumar Parayil, Abdul Hakkim Rahamathullah, Deborah McEwan US Patent WO 2017/142,993, 2017 | | 2017 |
| RhlR, but not RhlI, allows P. aeruginosa bacteria to evade Drosophila Tep4-mediated opsonization S Haller, A Franchet, A Hakkim, J Chen, E Drenkard, S Yu, S Schirmeier, ... bioRxiv, 165530, 2017 | | 2017 |
| Cell-based screening assay for inhibitors of net formation HW Abdul Hakkim Rahamathullah, Nancy E. Martinez, Fuchs, T., Zychlinky, A. EP Patent WO 2,012,065,720, 2012 | | 2012 |
Volker BrinkmannMax Planck Institute for Infection Biology在 mpiib-berlin.mpg.de 的电子邮件经过验证
